Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BInnopharmax Inc. 〉Innomustine®(Bendamustine)

Innomustine®(Bendamustine)

Innomustine®(Bendamustine)

Request for Collaboration
Overview
Bendamustine was synthesized to combine a purine and amino acid antagonist with an alkylating nitrogen mustard group (bifunctional alkylating agent). The major advantage of Bendamustine, compared to chlorambucil, is its favored water solubility. On the other hand, Bendamustine has been proven to be safe. It is indicated as single-agent therapy or in combination with other antineoplastic drugs for the treatment of the following malignancies: Hodgkin's disease (stages II-IV), non-Hodgkin's lymphoma (NHL), plasmocytoma; chronic lymphocytic leukaemia (CLL), and breast cancer. In March 25th, 2008, INNOPHARMAX has signed a license agreement with SymBio Pharmaceuticals Ltd. for the sublicense rights to Bendamustine HCl in Taiwan.
People who like this also like
  • Migus-Nutrients for DiabetesMigus-Nutrients for Diabetes
  • Other APIsOther APIs
  • Active Pharmaceutical Ingredients (APIs)Active Pharmaceutical Ingredients (APIs)
  • U2™ Cemented StemU2™ Cemented Stem
  • ctDNA Detection ServicectDNA Detection Service
  • GADOMNI®(Gadopentetate dimeglumine)GADOMNI®(Gadopentetate dimeglumine)
  • Plug Absorbable Wound Dressing Protector for DentistryPlug Absorbable Wound Dressing Protector for Dentistry
  • UCP™ StemUCP™ Stem
  • Spear Locking PlateSpear Locking Plate
  • AmCAD USAmCAD US